1-5 of 5
Ricki Englehaupt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

LFA-3/CD2 Pathway, Potential Target For Immunosuppressive Therapy In Aplastic Anemia: A Phase I/II Trial Of Alefacept In Patients With Relapsed/Refractory Aplastic Anemia

Ramon V. Tiu, MD, Valeria Visconte, PhD, Paul Elson, Michael J. Clemente, Ali Tabarroki, MD, Edy Hasrouni, Amy Porter, Lindsey Mooney, Manuel G. Afable, II, Ricki Englehaupt, Joy Juersivich, RN, MSc, Kathleen Cooper, RN, MSc, Mikkael A. Sekeres, MD, MS, Yogen Saunthararajah, M.D., Jaroslaw P. Maciejewski, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3711.
https://doi.org/10.1182/blood.V122.21.3711.3711
Published: 2013
Journal Articles

Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes

Clinical Trials & Observations
Mikkael A. Sekeres, Ramon V. Tiu, Rami Komrokji, Jeffrey Lancet, Anjali S. Advani, Manuel Afable, Ricki Englehaupt, Joyce Juersivich, David Cuthbertson, Jennifer Paleveda, Ali Tabarroki, Valeria Visconte, Hideki Makishima, Andres Jerez, Ronald Paquette, Alan F. List, Jaroslaw P. Maciejewski
Journal: Blood
Blood (2012) 120 (25): 4945–4951.
https://doi.org/10.1182/blood-2012-06-434639
Published: 2012
Includes: Supplemental data
Journal Articles

A Proof of Principle Clinical Trial in Myelodysplastic Syndromes of Non-Cytotoxic Differentiation Therapy with Decitabine,

Yogen Saunthararajah, MD, Reda Z Mahfouz, MD, Ricki Englehaupt, Joy Juersivich, RN, MSc, Lisa Durkin, Tomas Radivoyevitch, PhD, Kathleen Cooper, RN, MSc, Manual Afable, MD, Robert Dean, Anjali S. Advani, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Edward A. Copelan, MD, Eric D. Hsi, MD, Jaroslaw P. Maciejewski, MD, PhD, Mikkael A Sekeres, MD
Journal: Blood
Blood (2011) 118 (21): 3830.
https://doi.org/10.1182/blood.V118.21.3830.3830
Published: 2011
Journal Articles

Final Results From the Phase 2 Continuation Study of the Lenalidomide and Azacitidine Combination in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)

Mikkael A. Sekeres, MD, MS, Rami S. Komrokji, MD, Jeffrey E. Lancet, MD, Ramon V. Tiu, MD, Anjali S. Advani, MD, Manual Afable, Ricki Englehaupt, Joyce Juersivich, David Cuthbertson, M.S., Jennifer Paleveda, Ronald Paquette, MD, PhD, April Smith, Lori Strozniak, Alan F. List, MD, Jaroslaw P. Maciejewski, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 607.
https://doi.org/10.1182/blood.V118.21.607.607
Published: 2011
Journal Articles

Prior Therapy with DNA Methyltransferase Inhibitors (DNMTI) Predicts for Lower Remission Rates and Worse Survival In Secondary Acute Myeloid Leukemia Patients (sAML) Receiving Remission Induction Therapy

Sanjay R. Mohan, MD, Alex Fu, Ramon V. Tiu, MD, Edward Copelan, MD, Yogen Saunthararajah, MD, Anjali Advani, MD, Ronald Sobecks, MD, Manual Afable, Ricki Englehaupt, Katarina Paulic, Marc Earl, Pharm., D., R.Ph., Matt Kalaycio, MD, Jaroslaw P Maciejewski, MD, PhD, FACP, Mikkael A. Sekeres, MD, MS
Journal: Blood
Blood (2010) 116 (21): 4033.
https://doi.org/10.1182/blood.V116.21.4033.4033
Published: 2010